60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) EV-to-Revenue : 0.00 (As of May. 13, 2024)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 60 Degrees Pharmaceuticals's enterprise value is $0.00 Mil. 60 Degrees Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.25 Mil. Therefore, 60 Degrees Pharmaceuticals's EV-to-Revenue for today is 0.00.

The historical rank and industry rank for 60 Degrees Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

SXTPW' s EV-to-Revenue Range Over the Past 10 Years
Min: 35.57 Med: 123.89 Max: 224.75
Current: 41.31

During the past 4 years, the highest EV-to-Revenue of 60 Degrees Pharmaceuticals was 224.75. The lowest was 35.57. And the median was 123.89.

SXTPW's EV-to-Revenue is ranked worse than
76.16% of 1036 companies
in the Biotechnology industry
Industry Median: 7.96 vs SXTPW: 41.31

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), 60 Degrees Pharmaceuticals's stock price is $0.105. 60 Degrees Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, 60 Degrees Pharmaceuticals's PS Ratio for today is .

60 Degrees Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals EV-to-Revenue Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

54.10

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial						-	-	-	132.77	54.10

Competitive Comparison of 60 Degrees Pharmaceuticals's EV-to-Revenue

For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

60 Degrees Pharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where 60 Degrees Pharmaceuticals's EV-to-Revenue falls into.

60 Degrees Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

60 Degrees Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.000	/	0.254
	=	0.00

60 Degrees Pharmaceuticals's current Enterprise Value is $0.00 Mil.
60 Degrees Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.25 Mil.

60 Degrees Pharmaceuticals (NAS:SXTPW) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

60 Degrees Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.105	/
	=

60 Degrees Pharmaceuticals's share price for today is $0.105.
60 Degrees Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

60 Degrees Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.